Soluble B7-H3 in Ovarian Cancer and Its Predictive Value

Article Properties
Cite
Kovaleva, O. V., et al. “Soluble B7-H3 in Ovarian Cancer and Its Predictive Value”. Bulletin of Experimental Biology and Medicine, vol. 171, no. 4, 2021, pp. 472-4, https://doi.org/10.1007/s10517-021-05253-w.
Kovaleva, O. V., Belova, T. P., Korotkova, E. A., Kushlinskii, D. N., Gratchev, A. N., Petrikova, N. A., Kudlay, D. A., & Kushlinskii, N. E. (2021). Soluble B7-H3 in Ovarian Cancer and Its Predictive Value. Bulletin of Experimental Biology and Medicine, 171(4), 472-474. https://doi.org/10.1007/s10517-021-05253-w
Kovaleva, O. V., T. P. Belova, E. A. Korotkova, D. N. Kushlinskii, A. N. Gratchev, N. A. Petrikova, D. A. Kudlay, and N. E. Kushlinskii. “Soluble B7-H3 in Ovarian Cancer and Its Predictive Value”. Bulletin of Experimental Biology and Medicine 171, no. 4 (2021): 472-74. https://doi.org/10.1007/s10517-021-05253-w.
Kovaleva OV, Belova TP, Korotkova EA, Kushlinskii DN, Gratchev AN, Petrikova NA, et al. Soluble B7-H3 in Ovarian Cancer and Its Predictive Value. Bulletin of Experimental Biology and Medicine. 2021;171(4):472-4.
Journal Category
Medicine
Medicine (General)
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
10.1134/S1068162019040101 2019
B7-H3 is related to tumor progression in ovarian cancer Oncology Reports
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 28 2017
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis Prostate Cancer and Prostatic Diseases
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
 104 2017
Murine B7-H3 Is a Co-Stimulatory Molecule for T Cell Activation 20 2013
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3 Structure
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Physics
  • Science: Biology (General): Cytology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 81 2013
Refrences Analysis
Category Category Repetition
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens6
Medicine: Medicine (General)4
Medicine3
Science3
Science: Science (General)3
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology1
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 6 is the most frequently represented among the references in this article. It primarily includes studies from PLOS ONE and Prostate Cancer and Prostatic Diseases. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
B7-H3/CD276 and small-cell lung cancer: What's new? Translational Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 2024
B7-H3 Inhibitors in Oncology Clinical Trials: A Review

 Journal of Immunotherapy and Precision Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 2024
Soluble B7-H3 in Colorectal Cancer Bulletin of Experimental Biology and Medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2023
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

 Cells
  • Science: Biology (General): Cytology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General): Cytology
 11 2023
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer

 International Journal of Molecular Sciences
  • Science: Biology (General)
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
 2023
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)3
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens3
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy2
Science: Biology (General)2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
Science: Chemistry: General. Including alchemy1
Science: Chemistry1
Science: Biology (General): Cytology1
Science: Chemistry: Organic chemistry: Biochemistry1
The category Medicine: Medicine (General) 3 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled B7 family protein glycosylation: Promising novel targets in tumor treatment and was published in 2022. The most recent citation comes from a 2024 study titled B7-H3 Inhibitors in Oncology Clinical Trials: A Review. This article reached its peak citation in 2023, with 3 citations. It has been cited in 7 different journals, 57% of which are open access. Among related journals, the Journal of Immunotherapy and Precision Oncology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year